Premium
PK of 111 IN and 90 YT labeled KC‐4G3 in patients with prostate carcinoma
Author(s) -
Bednarczyk E.M.,
Forrest A.,
Farrell E.,
Nabi H.
Publication year - 1996
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/sj.clpt.1996.239
Subject(s) - prostate carcinoma , medicine , prostate , carcinoma , urology , oncology , cancer research , cancer
Clinical Pharmacology & Therapeutics (1996) 59 , 185–185; doi: 10.1038/sj.clpt.1996.239
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom